Trump leaves behind largely unworkable drug-pricing policies
Between legal challenges and practical implementation problems, President Trump isn’t leaving much policy for the Biden team to work with. But he did shift the drug-policy conversation.
Read the full article.
Tags
health care finance health care reform health law policy pharmaceuticals